Ischemia Possibly Associated with High Degree Atrioventricular Block
Dimitrios Siamkouris1, Elmar Offers1, Marc Schloesser1
1Department of Cardiology, Dreifaltigkeits Hospital Lippstadt, Germany, Academic Teaching Hospital of Westfaelische Wilhelms University Muenster, Muenster, Germany.
High-degree atrioventricular block (HAVB) may be reversible after revascularization in non-acute coronary syndrome patients. This case suggests potential for conduction recovery, though more research is needed.
Area of Science:
- Cardiology
- Electrophysiology
- Interventional Cardiology
Background:
- Second- and third-degree atrioventricular (AV) block management, especially in non-acute coronary syndrome (ACS) settings, remains challenging.
- Permanent pacemaker implantation is often considered for high-degree AV block (HAVB).
Observation:
- A patient with HAVB, initially referred for permanent pacemaker implantation, demonstrated spontaneous conduction restoration.
- This recovery occurred following targeted revascularization procedures.
Findings:
- The case highlights the potential for reversible HAVB in patients without ACS.
- Revascularization may play a role in restoring cardiac conduction in select non-ACS patients.
Implications:
- This finding suggests that revascularization could be a therapeutic consideration for HAVB in non-ACS patients.
- Further robust clinical studies are necessary to confirm these observations and establish guidelines.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...


